trial
type: MedicalStudy
name: Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
description: Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2008-05
end date: 2012-11
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00668200
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Paget's Disease of the Bone
study subject: Hypocalcemia
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Paget's Disease of the Bone
keywords: Hypocalcemia

AI Analytics
type: Organization